Press Releases

Press Releasesadmin2023-06-07T15:58:22-04:00

Most recent news

January 31, 2025

Virpax’s Matthew Barnes to Present at Outsourcing in Clinical Trials Conference

August 10, 2021

Virpax Pharmaceuticals Reports 2021 Second Quarter Results and Recent Developments
July 30, 2021

Virpax® Pharmaceuticals Strengthens Board of Directors with the Appointment of Gerald W. Bruce and Michael F. Dubin, CPA to its Board
July 7, 2021

Virpax Pharmaceuticals Provides Progress Update on Product Candidates
June 21, 2021

Virpax to Use Envelta™ IND Enabling Study Results for Two Additional Indications
May 18, 2021

Virpax Pharmaceuticals Reports 2021 First Quarter Results and Recent Developments
April 19, 2021

Virpax’s MMS019 Reduced Nasal and Brain Viral Load in Animal Study
April 5, 2021

Virpax Announces Results of Probudur(TM) in Animal Study
March 22, 2021

Virpax to Initiate Investigational New Drug (IND) Enabling Studies for Probudur(TM) for Postoperative Pain
March 10, 2021

Virpax to Initiate Investigational New Drug (IND) Enabling Studies for Epoladerm(TM)
March 2, 2021

Virpax Pharmaceuticals Announces Newly Issued Patent for Probudur(TM)
February 23, 2021

Virpax Begins IND Enabling Studies of Envelta(TM)
February 19, 2021

Virpax Pharmaceuticals Announces Closing of Initial Public Offering
February 16, 2021

Virpax(R) Pharmaceuticals Announces Pricing of Initial Public Offering
December 7, 2020

Virpax’s MMS019 Inhibits SARS-COV-2 in Ex-Vivo Airway Model

Previous 678 Next

BUSINESS INQUIRIES

Virpax Pharmaceuticals, Inc.
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312
610.727.4597
‍info@virpaxpharma.com

MEDIA INQUIRIES

Public Relations
Virpax Pharmaceuticals, Inc.
‍pr@virpaxpharma.com

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

© Virpax^® Pharmaceuticals. All Rights Reserved.

© Virpax^® Pharmaceuticals. All Rights Reserved.

Follow @VirpaxPharma

Follow @VirpaxPharma